Jasper Therapeutics Inc. Watch

from 8-K 22 pages Whereas, in Order to Finance the Company’s Transaction Costs in Connection With an Intended Initial Business Combination (As Defined Below), the Sponsor or an Affiliate of the Sponsor or Certain of the Company’s Officers and Directors May, but Are Not Obligated To, Loan the Company Funds as the Company May Require, of Which Up to $1,500,000 of Such Loans May Be Convertible Into Up to an Additional 1,500,000 Private Placement Warrants at a Price of $1.00 Per Warrant (The “Working Capital Warrants”); And